As TGF-β1 is increased in COPD [15], [16] it is a reasonable assumption that cells in the COPD airways in-vivo are more likely to produce FBLN-1 in comparison to the cells from non-diseased airways, in which TGF-β1 level may not be raised. Here, FBLN1 is linked to chronic obstructive pulmonary disease.